chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SORE FEELING AT INJECTED SITE; This spontaneous report received via social media from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced sore feeling at injected site. The action taken with covid-19 vaccine  was not applicable. The outcome of sore feeling at injected site was not reported. This report was non-serious. This case, from the same reporter is linked to 20210506606.
left face numbness; moderate pain up the left side of neck 8 hours after injection,; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration on right arm on 18Mar2021 at 09:45 (at the age of 51 year) as a single dose for COVID-19 immunisation. Past medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Concomitant medication included olmesartan (MANUFACTURER UNKNOWN) from an unspecified date for an unknown indication and CENTRUM MEN 50+ MULTIVITAMIN from an unspecified date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 17:45 the patient experienced moderate pain up the left side of neck. On 18Mar2021 at 21:45 the patient experience face numbness. The patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care visit for the event occurred. No no treatment was taken in response to the event. It was reported that on the day of vaccination, the patient experienced moderate pain up the left side of neck, the patient took a nap and woke with left face numbness approximately 12 hours after the injection. the patient. The clinical outcome of the event neck pain and facial numbness was not recovered. No follow-up attempts are needed. No further information is expected
Information received from a physician, pt received vaccine in right deltoid. Pt developed local tenderness. Treated with application of cold compress, pt recovered
Caregiver stated that the patient received both Moderna vaccines, but still got Covid.; This spontaneous case was reported by an other caregiver and describes the occurrence of COVID-19 (Caregiver stated that the patient received both Moderna vaccines, but still got Covid.) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     The patient's past medical history included Anorgasmia (No orgasms), Paralyzed, Optic neuritis, COVID-19 and Coma. Concurrent medical conditions included Forgetfulness (Forgetting everything), Pain, Burning sensation and Weight gain. Concomitant products included OCRELIZUMAB (OCREVUS) and OXYGEN for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caregiver stated that the patient received both Moderna vaccines, but still got Covid.) (seriousness criterion hospitalization). At the time of the report, COVID-19 (Caregiver stated that the patient received both Moderna vaccines, but still got Covid.) had resolved.            Ocrevus stops working. Concurrent conditions reported: lesions, location not provided  No treatment information was provided.  Patient had Medically history of lesions.  Company Comment: This is a spontaneous case concerning an adult female patient (exact age unknown) with no relevant medical history, who experienced the serious (due to hospitalization) unexpected, event of COVID-19. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. Temporal association cannot be assessed due to lack of information on onset date of the event and vaccination date. The outcome was reported as recovered. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning an adult female patient (exact age unknown) with no relevant medical history, who experienced the serious (due to hospitalization) unexpected, event of COVID-19. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. Temporal association cannot be assessed due to lack of information on onset date of the event and vaccination date. The outcome was reported as recovered. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
12/21/99, presented w/lump on L/deltoid "from Flu shot" received 10/21/99. On 1/14/00, recheck of arm shows increased size & tenderness. I & D of sterile Abscess done w/wick placement. On 1/17/00, replaced wick. To return in 2 days to check
Client reported mild tenderness at injection site starting day of vaccination (6/28). Two days (6/30)following vaccination, client reported onset of itchiness and erythema around area of injection. RN assessed injection site (7/1) and appreciated reddened, oval-shaped area was approximately 2" in width and 3" in length. Area felt warm to touch. Client endorsed mild but diminishing tenderness to site. No hives, angioedema, respiratory distress, or other evidence of complication or anaphylaxis noted. Client counseled on monitoring and comfort measures. RN assessed injection site (7/3) and noted erythema mostly resolved. Client denied additional symptoms or complications and reported to be afebrile.
At site of injection patient experienced a raised, red swollen area approx. 5 inches diameter. Painful to touch. As of 2 pm 4/1/16 symptoms improving. As of 2 pm 4/2/16 improved much more. Cephalexin prescribed - Patient did not use Cephalexin.
Patient last vaccine 02/24/21. Received Juvederm treatment 04/12/2021 for facial wrkinkling, dermatologist .  Developed eye pain/ eye sensitivity (without visble conjunctivitis by husband reported who is MD) approximately  04/05/2021.  Patient used Visine eye drops for irritated eyes.  On 04/19/2021 developed redness and swlling nose bridge and forehead, went to see (dermatologist) thinking this to be from the Juvederm injections.  In office diagnosed herpes/shingles, in meantime a pustule/herpetic lesion developed on forehead (picture available). Patient contacted Kaiser and went to Urgent Care, seen referred to dermatology prescribed Valtrex. see page 2Dermatology and seen: diagnosed with varicella zoster .   Also referred to Ophthalmology and seen, diagnosed with Right Herpes Zoster Conjunctivitis.  Prescribed Valtrex PO and Erythromycin opht ointment.   Of concern is that patient received Zoster vaccine in 2009 (?Zostavax, and one dose Shingrix  2018.  Has to her knowledge never had shingles or zoster.  There is no other underlying morbidity specifically no autoimmune conditions such as rheumatoid arthritis or Sjogren disease.  No known contact with persons with shingles or herpes zoster.   The concern is development of zoster and herpetic conjunctivitis  after recent COVID vaccination and Juvederm treatment, while having been vaccinated with Zoster vaccine and Shingrix, without known previous or apparent underlying autoimmune conditions.
This spontaneous report as received from an office manager refers to a patient of unknown age. The patient was vaccinated with lot # (669631/0156AA) an unspecified dose of M-M-R II on 29-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. The patient was administered a dose of MMRII that had been exposed to 5 temperature excursions to a high temperature of 55 degrees Fahrenheit for an unsupportable cumulative total of 8.5 hours (Excursion dates 27-JUL-2012 for 1.5 hours; 08-SEP-2012 for 3 hours; 09-SEP-2012 for 4 hours). No adverse effect was reported. No treatment information was reported. No further information is available. This case is linked to case MARRS # 1211USA011055, 1211USA012758 and 1212USA000925 (same reporter). Additional information is not expected.
Low grade 100-101 fever on the 25th of Sept and large erythematous welts very indurated over all sites but 1 hour over site of DTaP and Prevnar.
I received the shingles shot on 8/27/09 - by 9/1/09 I had blisters on my hands and feet-the skin came off toes and hands-I still have this as of 10/13/09. The Dr. gave me Ciclopirax Cream for this condition, under my left shoulder blade, inside, it burns and itches terribly.
Swollen and sore lymph node right neck; Swollen and sore lymph node right neck; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 07Mar2021 12:15 (Lot number: EN6205) at the age of 67 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SIMVASTATIN; CALCIUM +D. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 08Mar2021 10:00, outcome "not recovered" and all described as "Swollen and sore lymph node right neck". Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain.  Additional information: This report was received via COVAES. The patient was not pregnant at time of vaccination. The patient had no known allergies. The patient did not undergo COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. The patient did not receive other vaccine in four weeks. The patient's concomitant medications SIMVASTATIN; CALCIUM +D; "MULTIVITAMIN"; all taken for an unspecified indication, start and stop dates were not reported.   No follow-up attempts are possible. No further information is expected.
Pfizer monovalent covid vaccine given instread of bivalent Pfizer covid vaccine.
This is a spontaneous report from a non-contactable consumer (patient's friend). A 10-decades-old female patient (reported as in her 90's) received PREVNAR 13, via an unspecified route of administration on 30Aug2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient had some problems with her arm movement, as well as pain, and stiffness in her neck on an unspecified date in 2018. The patient wanted to know if limitation of arm movement was a common side effect with pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein). Outcome of the events was unknown. No follow up attempts are possible. No further information is expected.
Pt had immediate site reaction redness, irritation, pain redness continued to increase and spread until pt went to urgent care the following day.
Headache, Arthralgia,  burning, discomfort,runny nose, fatigue, body aches Narrative:
Shortly after shot arm became hard to move. Next day, April 14th, arm was very sore and had issues raising it above collar bone without pain in arm or shoulder.  Next day soreness went away and everything was fine until April 17th. I went to dinner with my family and started getting a headache on the way back. I laid down for an hour and a half, but the pain was just as bad. After getting up I took Tylenol and it seemed to make the pain go away. On Sunday, April 18th, I woke up with sever pain from my shoulder, neck, and head. I also had body aches and my eyes were really sore. Looking side to side was really painful. I was only awake from 1 to 5. I slept the rest of the day and didn?t have much of an appetite. I?m pretty sure I had a fever at one point because I got chills, but I didn?t take my temperature. The next day, April 19th, I called into work because I was still having the same shoulder, neck, and head pain along with the eye soreness. I took ibuprofen around 12pm, and started feeling a bit better. I still had no real appetite; I ate cause I knew I needed to and very little. That night I was running a 100.4 fever. Throughout the night I had chills and hot spells. I woke up in the middle of the night and my pants and shirt were drenched in sweat. I woke up this morning, April 20th, feeling much better. I only have slight discomfort with my eyes and my appetite is back. I am currently running a low grade fever of 99.2 which is causing me to sweat badly.  Hopefully the worst is over.
Pfizer -pediatric was not diluted prior to administering.  was not discovered until later on that evening.
patient expired 1/15/2021; had been treated as outpatient for pneumonia, likely COVID-19 but no positive test result in December 2020. PMH diabetes
Had the vaccine and still had it super bad/suspected Vaccination failure; still had it super bad, horrible; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 27-APR-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the vaccine and still had shingles super bad. The patient had them for month and a half. It was horrible. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
high fever, (103-104) nausea, vomiting, body aches, It felt like i had COVID all over again. It lasted 3 days at this rate then by day 5 I was able to return to work. I have not taken the 2nd shot at this time because I am afraid to do so.    I have also had heart palpitations since taking this first shot.
a blotchy red little rash; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (a blotchy red little rash) and HEADACHE (slight headache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (a blotchy red little rash) and HEADACHE (slight headache). At the time of the report, RASH ERYTHEMATOUS (a blotchy red little rash) and HEADACHE (slight headache) outcome was unknown. Not provided. No concomitant medications were provided. Treatment information was not provided by reporter. This case was linked to MOD21-078429, MOD21-078495, MOD21-078496 (E2B Linked Report). This case was linked to MOD-2021-080606 (Patient Link); Sender's Comments: MOD21-078429: MOD21-078495: MOD21-078496:
A report has been received from a Medical rep concerning a female patient. Patient relevant history, concurrent diseases and concomitant drugs were not reported. On 15-Oct-2015, patient received nasal FLUMIST (intranasal) for flu vaccination. Reporter stated that patient tested positive for flu type A on 04-Jan-2016, and was ill for 4 days. The outcome of flu was unknown. Company physician considered flu to be non serious.
This is a spontaneous report from a contactable consumer (patient). A 51-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: FL3302) via an unspecified route of administration on 12Jan2021 at single dose for COVID-19 Immunization. There was no medical history. There were no concomitant medications. The patient reported a side effecting occurrence with COVID-19 Vaccination he received about a week ago. He experienced two days after the vaccination has been given to him, on 14Jan2021, that was on day three or two days later of the vaccination; and then again second yesterday (17Jan2021), that was on day five, some pain in the stomach and it was kind of a (Incomplete sentence), it appeared heavily and then he needed to go to the toilet and the first time it was only once and the second time there was two reactions like the other. No treatment received for event. He did lab test some months ago. Event outcome was recovering, it was very slightly not anymore.
One week post 1st vax pt developed mild arthritis symptoms mostly in hands, lasted one week. 7/17/00 2nd shot given and 1 week post vax pt developed stiff joints, mostly in hands, wrist, feet, and finger, mainly in knee and back lasted 1 month - 6 weeks. Patient states saw MD taking Advil still having flare ups.
Pt started with rash at inner arm on elbow joint and behind knee on the day after she got the shot. Rash getting worse for 5 days after shot. She had taken BENADRYL for last 36 hours.
Extreme loss of use of arm almost immediately. Unable to lift due to severe pain. Muscle pain into the shoulder and up into the neck which also affects the left ear. Unable to use arm in a motion but can use hand. Very extremely painful.
reddened area around site of inject w/bubble @ point of entry; tiny pus collection around punctum: imp early folicultits/cellulitis;
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Vaccine administered 5/4/13 R deltoid 8:45pm. Complaint of moderate pain at injection site on 5/5/13 6:25AM. Tylenol and cold packs utilized. 5/5/13 9:22pm complaint of R upper arm redness and warm to touch. Temp 99.4. MD notified. Keflex 500mg po QID x 7 days. Elevate arm. 5/6/13 Redness improved. Feeling better. 5/7/13 Continues to improve. 5/8/13 Nearly resolved. 5/9/13 Resolved.
Slight fever, red area/rash of approximately 1 ½ of diameter (irregular shape).  I took an Aleve (over the counter), no other treatment.
Pt given vax & approx 9AM started crying @ 3PM to 730PM pt fell asleep; pt given Tempra only while awake every 4 hrs; pt awakened @ 5AM on 3NOV92 & has been crying til call 245PM will not stop crying to eat or drink x/for sips of 7UP;
Hives all over body (unraised, red blotches). Lasting 24+ hours.
The patient's daughter reported he had been feeling fatigue since his COVID vaccine on 5/10/21 along with frequently feeling cold. On 6/27/21, the patient had an out of hospital cardiac arrest with prolonged CPR, reportedly continuing for 25 minutes. He was diagnosed with hypothyroidism resulting in myxedema coma. After the cardiac arrest, he was also found to have severe left ventricular systolic dysfunction (ejection fraction of 10%), a small cerebellar stroke, and progression of his chronic CKD to end stage renal disease. He was also intubated during the cardiac arrest and remained on a ventilator as of today (7/4/21). With all sedating medications held for 6 days, he has had no apparent meaningful neurologic function.
Pt recvd 3 doses of Engerix-B & 3DEC91 & it was determined that pt did not respond to the vax series;
Patient was complaining of fatigue, lightheadedness, productive cough progressively worsening over the last few days, some shortness of breath, at baseline, no fever or chills, she did have exposure to corona virus disease 19 few weeks ago, she has received 1 dose of J NJ vaccine, no chest pain. Evaluation in the emergency department revealed elevated blood pressure at 174/76, elevated temperature at 99.4° F, procalcitonin was mildly elevated at 0.12, salicylate level less than 2, urine analysis suggestive of urinary tract infection with 35 white blood cells per high-power field, positive nitrate and moderate leukocyte esterase, CBC showed mild thrombocytopenia with platelet count 129, troponin normal, acetaminophen level less than 2, comprehensive metabolic panel showed elevated BUN at 25 and creatinine at 1.2, elevated calculated globulin at 4.1, CK total 34, magnesium 2.1, lactic acid 1.3, ethanol level less than 3. Chest x-ray did not show acute cardiopulmonary process.  Patient EKG showed normal sinus rhythm, left bundle branch block.  She was admitted for further care.   Hospital Course:  Patient was treated with ceftriaxone for urinary tract infection, Proteus mirabilis on cultures, will prescribe Cipro on discharge.  She denies any shortness of breath, cough or sputum, she is already vaccinated against corona virus disease 19, she was given vitamin-C, zinc, vitamin-D.  She was given IV fluids for acute kidney injury, losartan was stopped, renal function is back to normal, she did have problems with fall on January 18th while patient was in bathroom, was seen by OT and PT. Post-acute therapy screen recommended by Occupational and Physical therapy, patient's daughter would like to take her home, she declined home health care. She had Syncopal episode while in the bathroom on January 20th in the evening, patient was given fluid bolus, no further symptoms, no acute process on head CT, Carotid Doppler showed Extensive hard and soft atheromatous plaque at the carotid bifurcation bilaterally. Hemodynamically there is stenosis in the range of 50-69% in the origin of the ICAs bilaterally somewhat more on the right compared to left.  Moderate atherosclerotic stenosis in the origin of the left ECA. Antegrade flow is seen in the vertebral arteries bilaterally, echocardiogram showed preserved left ventricular systolic function, her daughter declined further workup and requested discharge home, declined home care as well, will discharge home, close follow up with PCP
Pt exposed and infected with Covid-19 virus after receiving Covid-19 Vaccine on 3/30/21, confirmed positive test on 7/27/2021.
"pt vomited cookie & juice approx 10min p/vax;BP 118/68, P84, R20;"
3"x3" area of blanching erythema right lateral thigh. Benadryl 40mg every 6 hours for 24-72 hours.
I had aches and pains in the joints and it took my energy away. I had a yellow bruise on at the injection site. I also had a bad headache. It felt like I had COVID-19 again. This lasted for about 5 days.